Ciphergen Biosystems, Inc.
Sale of BioSepra chromatography business affects financial results
Published in Physician Law Weekly, March 23rd, 2005
Because of the sale of Ciphergen's BioSepra chromatography business to Pall Corp. on November 30, 2004, the financial results discussed herein reflect the BioSepra business as a discontinued operation.
For the quarter ended December 31, 2004, total revenue decreased 13% to $10.1 million, as compared to $11.6 million in the fourth quarter of 2003; but total revenue increased 19% sequentially as compared to the third quarter of 2004. The net loss from continuing operations was $7.6 million in the fourth quarter of 2004 as...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2005-03-23)
More Articles from Physician Law Weekly
- Alzheimer Disease
Diagnoses of Alzheimer disease expected to increase - Bioterrorism
Interpol lays out measures to combat bioterrorism - Emory University, Atlanta
Factors associated with victimization of African American female DUs identified - Gender Medicine
Thailand Ministry to campaign for breast-enlargement exercise - HIV/AIDS Testing
Expectant mothers urged to get tested for AIDS - Healthcare Coverage
Illinois House allows people to pick and choose in health insurance - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
